Nabriva's pneumonia drug succeeds in late-stage study

(Reuters) - Nabriva Therapeutics Plc's pneumonia drug for adults met the main goal of a late-stage study, the company said on Monday, putting it on track to file a marketing application with U.S. regulators later this year.

Source: Reuters: Health - May 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news